• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions
【24h】

Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions

机译：居住在养老院的老年人的药剂师对临床药物的审查：药剂师的干预措施

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objectives To describe the rate and nature of pharmacist interventions following clinical medication review of elderly people living in care homes. Setting Care home residents aged 65+ years, prescribed at least one repeat medication, living in nursing, residential and mixed care homes for older people in Leeds, UK. Method Analysis of data from care home residents receiving clinical medication review in the intervention arm of a randomised controlled trial. Intervention outcomes for each medicine were evaluated for each resident. Key findings Three-hundred and thirty-one residents were randomised to receive a clinical medication review and 315 (95%) were reviewed by the study pharmacist; 256 (77%) residents had at least one recommendation made to the general practitioner. For the 2280 medicines prescribed, there were 672 medicine-related interventions: medicines for cardiovascular system (167 (25%)), nutrition and blood (121 (18%)), central nervous system (113 (17%)) and gastrointestinal conditions (86(13%)) accounted for 487 (73%) of medicine-related interventions. There were 75 non-medicine-related interventions. The most common interventions were 'technical' (225 (30%)), 'test to monitor medicine' (161 (22%)), 'stop drug' (100 (13%)), 'test to monitor conditions' (75 (10%)), 'start drug' (76 (10%)), 'alter dose' (40 (5%)) and 'switch drug' (37 (5%)). Recommendations to stop a medicine were most common for CNS drugs (32 (32%)). The most common medicine to be recommended to be started was calcium and vitamin D (45 (59%)). Following a recommendation to test to monitor a medicine, 23 (14%) medicines required a change. Conclusions This study has demonstrated that clinical medication review by a pharmacist can identify medicine problems in approximately 80% of care home residents, requiring intervention in 1 in 4 of their prescribed medications.
机译：目的描述对居住在养老院中的老年人进行临床用药审查后，药剂师干预措施的发生率和性质。在英国利兹，为65岁以上的老年人设置护理之家，他们至少开出一种重复药物，住在养老院，住宅和混合护理之家。方法分析来自随机对照试验的干预组中接受临床药物审查的疗养院居民的数据。对每位居民的每种药物的干预结果进行了评估。主要发现301名居民被随机分配接受临床药物审查，研究药剂师对315名居民（95％）进行了审查。 256（77％）位居民对全科医生提出了至少一项建议。在2280种处方药中，有672种与药物有关的干预措施：心血管系统药物（167（25％）），营养和血液药物（121（18％）），中枢神经系统药物（113（17％））和胃肠道疾病（86（13％））占与医学有关的干预措施的487（73％）。有75种与医学无关的干预措施。最常见的干预措施是“技术”（225（30％）），“测试以监测药物”（161（22％）），“停药”（100（13％）），“测试以监测病情”（75 （10％）），“起始药物”（76（10％）），“变更剂量”（40（5％））和“转换药物”（37（5％））。中枢神经系统药物最常见的停药建议（32（32％））。建议开始使用的最常见药物是钙和维生素D（45（59％））。在建议进行测试以监测某种药物后，有23种（14％）药物需要更换。结论该研究表明，由药剂师进行的临床用药审查可以在大约80％的疗养院居民中发现药物问题，需要干预他们处方药中的四分之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号